238 related articles for article (PubMed ID: 32113468)
1. Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in Europe.
Becskei C; Liebenberg J; Thys M; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):100. PubMed ID: 32113468
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of five common tick species infesting dogs in the USA.
Kryda K; Mahabir SP; Chapin S; Holzmer SJ; Bowersock L; Everett WR; Riner J; Carter L; Young D
Parasit Vectors; 2020 Mar; 13(1):77. PubMed ID: 32113476
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of Ixodes scapularis on dogs.
Holzmer S; Kryda K; Mahabir SP; Everett W
Parasit Vectors; 2020 Mar; 13(1):76. PubMed ID: 32113473
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.
Becskei C; Fias D; Mahabir SP; Farkas R
Parasit Vectors; 2020 Mar; 13(1):72. PubMed ID: 32113486
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra
Packianathan R; Hodge A; Bruellke N; Jackson C; Maeder S
Parasit Vectors; 2020 Sep; 13(1):448. PubMed ID: 32891172
[TBL] [Abstract][Full Text] [Related]
6. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs.
Kryda K; Mahabir SP; Carter L; Everett WR; Young DR; Meyer L; Thys M; Chapin S; Holzmer SJ; Becskei C
Parasit Vectors; 2020 Mar; 13(1):57. PubMed ID: 32113466
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA.
Kryda K; Mahabir SP; Inskeep T; Rugg J
Parasit Vectors; 2020 Mar; 13(1):98. PubMed ID: 32113472
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
Geurden T; Becskei C; Grace S; Strube C; Doherty P; Liebenberg J; Mahabir SP; Slootmans N; Lloyd A; Six RH
Vet Parasitol; 2016 May; 222():33-6. PubMed ID: 27068640
[TBL] [Abstract][Full Text] [Related]
9. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA.
Becskei C; Kryda K; Fias D; Follis SL; Wozniakiewicz M; Mahabir SP; Farkas R
Parasit Vectors; 2020 Mar; 13(1):70. PubMed ID: 32113470
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs.
Becskei C; Thys M; Kryda K; Meyer L; Martorell S; Geurden T; Dreesen L; Fernandes T; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):99. PubMed ID: 32113471
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced ascarid infections in dogs.
Becskei C; Kryda K; Thys M; Holzmer S; Bowersock L; Fernandes T; Meyer L; Reinemeyer C; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):71. PubMed ID: 32113482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogs.
Becskei C; Thys M; Doherty P; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):64. PubMed ID: 32113483
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States.
Six RH; Everett WR; Young DR; Carter L; Mahabir SP; Honsberger NA; Myers MR; Holzmer S; Chapin S; Rugg JJ
Vet Parasitol; 2016 May; 222():28-32. PubMed ID: 26935819
[TBL] [Abstract][Full Text] [Related]
14. Immediate and persistent efficacy of sarolaner (Simparica™) against Haemaphysalis elliptica on dogs.
Fourie JJ; Liebenberg JE; Crafford D; Six R
Parasit Vectors; 2019 Sep; 12(1):431. PubMed ID: 31488194
[TBL] [Abstract][Full Text] [Related]
15. Comparative speed of kill of sarolaner (Simparica
Packianathan R; Hodge A; Bruellke N; Davis K; Maeder S
Parasit Vectors; 2017 Feb; 10(1):98. PubMed ID: 28222813
[TBL] [Abstract][Full Text] [Related]
16. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Rhipicephalus sanguineus s.l. on dogs.
Six RH; Young DR; Holzmer SJ; Mahabir SP
Parasit Vectors; 2016 Feb; 9():91. PubMed ID: 26896456
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto
Reif KE; Bickmeier NP; Herrin BH; Dryden MW; Normile DM; Jesudoss Chelladurai JRJ; Miller KR; Flowers MR; Kang Q
Parasit Vectors; 2023 Nov; 16(1):440. PubMed ID: 38012748
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new spot-on formulation of selamectin plus sarolaner against four common tick species infesting cats in Europe.
Geurden T; Becskei C; Vatta AF; Slootmans N; von Reitzenstein M; King VL; Lin D; Rugg D
Vet Parasitol; 2017 Apr; 238 Suppl 1():S3-S7. PubMed ID: 28395754
[TBL] [Abstract][Full Text] [Related]
19. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard against induced infestations of Ixodes scapularis on dogs.
Six RH; Young DR; Myers MR; Mahabir SP
Parasit Vectors; 2016 Feb; 9():79. PubMed ID: 26876891
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sarolaner (Simparica
Oda K; Yonetake W; Fujii T; Hodge A; Six RH; Maeder S; Rugg D
Parasit Vectors; 2019 Oct; 12(1):509. PubMed ID: 31666109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
